Author： Milne Christopher-Paul
Publisher： Adis International
ISSN： 1364-9027
Source： International Journal of Pharmaceutical Medicine, Vol.20, Iss.5, 2006-01, pp. : 297-301
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Incentives for paediatric drug development in Europe
Inpharma, Vol. 1, Iss. 1506, 2005-01 ,pp. :
Access to resources
Recommend
Ethical, Regulatory and Scientific Challenges in Paediatric Drug Development
By Rose Klaus
Pharmaceutical Medicine, Vol. 22, Iss. 4, 2008-01 ,pp. :
Risk Assessment in Drug Development: Autoimmunity
Journal of Toxicology and Environmental Health, Vol. 69, Iss. 9, 2006-05 ,pp. :
By Krekels Elke HJ Anker John N van den Baiardi Paola Cella Massimo Cheng Katharine Y Gibb Diana M Green Hannah Iolascon Achille Jacqz-Aigrain Evelyne M Knibbe Catherijne AJ Santen Gijs WE Schaik Ron HN van Tibboel Dick Pasqua Oscar E Della
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. :